−0.31USD
−8.89 MUSD
28.70 M
About Entera Bio Ltd.
Sector
CEO
Miranda J. Toledano
Headquarters
Jerusalem
Website
Employees (FY)
37
Founded
2009
ISIN
IL0011429839
FIGI
BBG000R1K184
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH, GLP-E, and hGh, The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
ENTX Stock Analysis 1W 24/06/21Hello everyone , as we all know the market action discounts everything :) We can tell from all the signs and indicators that the ENTX stock is moving in a strong uptrend , all the data that we gathered and saw on the chart looks makes the market is in a great place to buy .
I am seeing 2 ways the m
ENTX - Entera Bio Ltd on huge run - possible double againI bought this one several days ago and there is still a huge amount of upside. If it can get through the $4.30 and $4.80 resistance a double is a real deal. They have had solid revenues the last 2 Q and are based in Isreal. They have partnered in a project with Amgen and have been around I think si
ENTX : Downside Vs Upside AnalysisTrend breakout analysis for ENTX:
Much more upside than downside from here as consolidation persists.
News from final 6months interim coming up in Q2 could bring good Volume back to this stock.
Shorts have been taking this stock hostage for a while now.. Longs will have a nice come back to newer h
$ENTX PT 6-10 and higherEntera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, an oral parathyroid hormone product candidate, which is in P
ENTX Cup and Handle? Or am I way off?Hey everyone! I'm new to trading and learning to spot patterns. This looks like a cup and handle to me. From what I understand, cup and handle patterns are supposed to be easy money. Feedback would be much appreciated! Thanks!
ENTX: Bullish Flag (107%)Bullish Flag (107%)
Pros:
Volume during post formation
Descending volume during flag formation
Golden cross in blue
PPS above 50MA and 200MA
RS above 0 and ascending
R/R ratio above 5
ATR ascending
200MA ascending, barely
250RSI above 50 and ascending
Cons:
Gap may be filled back to 1.60$
Target:
P
ENTX OBSERVED BREAKa reference for how a break out can be so incredibly fast
a nice gentle retest and then fireworks!
$ENTX Entera Bio Ltd Announces Positive Topline EB613 Phase 2Entera Bio Ltd Announces Positive Topline EB613 Phase 2 Biomarker Data
‒ Trial Met Primary Endpoint of Significant Increase in P1NP Based on Final Analysis of 3 Month Data
‒ Final Analysis of 6-Month Data, Including Change in Bone Mineral Density, Expected in Q2:21
‒ The trial’s primary endpoint
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ENTX is 1.99 USD — it has decreased by 11.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Entera Bio Ltd. stocks are traded under the ticker ENTX.
Entera Bio Ltd. is going to release the next earnings report on Jun 27, 2024. Keep track of upcoming events with our Earnings Calendar.
ENTX stock is 17.44% volatile and has beta coefficient of −0.07. Check out the list of the most volatile stocks — is Entera Bio Ltd. there?
One year price forecast for Entera Bio Ltd. has a max estimate of 10.00 USD and a min estimate of 10.00 USD.
ENTX earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.09 USD resulting in a 11.11% surprise. The estimated earnings for the next quarter are −0.08 USD per share. See more details about Entera Bio Ltd. earnings.
Entera Bio Ltd. revenue for the last quarter amounts to 14.00 K USD despite the estimated figure of 90.00 K USD. In the next quarter revenue is expected to reach 100.00 K USD.
Yes, you can track Entera Bio Ltd. financials in yearly and quarterly reports right on TradingView.
ENTX stock has fallen by 27.64% compared to the previous week, the month change is a 40.14% rise, over the last year Entera Bio Ltd. has showed a 134.12% increase.
ENTX net income for the last quarter is −2.00 M USD, while the quarter before that showed −2.38 M USD of net income which accounts for 16.14% change. Track more Entera Bio Ltd. financial stats to get the full picture.
Today Entera Bio Ltd. has the market capitalization of 79.48 M, it has increased by 4.84% over the last week.
No, ENTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ENTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Entera Bio Ltd. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 37.00 employees. See our rating of the largest employees — is Entera Bio Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Entera Bio Ltd. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Entera Bio Ltd. stock shows the strong buy signal. See more of Entera Bio Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Entera Bio Ltd. future price: according to them, ENTX price has a max estimate of 10.00 USD and a min estimate of 10.00 USD. Read a more detailed Entera Bio Ltd. forecast: see what analysts think of Entera Bio Ltd. and suggest that you do with its stocks.